Business Context and Reporting Period
Company: Collegium Pharmaceutical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 12, 2015
Reporting Period: Quarterly period ended September 30, 2015
This filing serves as a notification that the company issued a press release on November 12, 2015, announcing its financial results for the quarter ended September 30, 2015. The full text of the press release is included as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1), which is referenced but not detailed in the body of this 8-K form.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the issuance of results for the period ended September 30, 2015.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. These disclosures are expected to be found in the attached press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 12, 2015) for specific revenue, net loss, and cash position figures.
- Verify the company's cash runway and burn rate as disclosed in the press release.
- Check for updates on clinical trial progress or regulatory milestones mentioned in the press release.
- Confirm any forward-looking statements or guidance provided in the attached exhibit.